Completed PHASE2 INTERVENTIONAL 2-arm NCT06126328

Materna Prep Study Phase II (EASE)

EASE Study: A Randomized, Controlled Study to EvAluate the Safety and Effectiveness of the Materna Prep Device to Pre-stretch the Vaginal Canal and Pelvic Floor Muscles in Preparation for Vaginal Delivery

Sponsor: Materna Medical

Conditions Pelvic Organ Prolapse Vaginal Delivery

Interventions Materna Prep Device

Updated 5 times since 2023 Last updated: Feb 1, 2024 Started: Sep 8, 2021 Primary completion: Mar 23, 2023 Completion: Oct 12, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Pelvic Organ Prolapse and Vaginal Delivery, this trial is completed. The trial is conducted by Materna Medical and has accumulated 5 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Mar 2024 — Jul 2024 [monthly]

Completed PHASE2
Jan 2024 — Mar 2024 [monthly]

Completed PHASE2

Status: Withheld → Completed · Phase: None → PHASE2
Dec 2023 — Jan 2024 [monthly]

Withheld

First recorded

Sep 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Materna Medical

Data source: Materna Medical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Birmingham, United States , Camden, United States , Cleveland, United States , Columbus, United States , Houston, United States , Los Angeles, United States , Mountain View, United States , New Brunswick, United States , New York, United States , Newark, United States and 3 more locations